查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1806649

按产品类型、技术、最终用户和应用分類的单细胞定序市场—2025-2030 年全球预测

Single Cell Sequencing Market by Product Type, Technology, End User, Application - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 198 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计单细胞定序市场规模在 2024 年将达到 24.9 亿美元，2025 年将达到 28.3 亿美元，到 2030 年将达到 54.5 亿美元，复合年增长率为 13.94%。

主要市场统计数据
基准年2024年 24.9亿美元
预计2025年 28.3亿美元
预测年份 2030 54.5亿美元
复合年增长率（%） 13.94%

揭示单细胞定序在现代研究中的变革力量及其在精准医疗和生物技术突破中的关键作用

在精准医疗和创新生物技术的时代，单细胞定序已成为一种突破性的工具，能够以前所未有的分辨率揭示细胞异质性。这项技术使研究人员能够在单一细胞层面揭示组织的复杂性，为癌症生物学、免疫学、发育生物学等领域的突破铺平了道路。

随着新的液滴和微孔技术重新定义研究边界和临床应用，绘製单细胞定序的演变过程

过去十年，随着微流体液滴系统、微孔平台和高通量板式解决方案的兴起，单细胞定序经历了变革性的变化。液滴式方法透过将单一细胞封装在纳升液滴中，实现了单次运行中数万个细胞的平行处理，从而实现了细胞的普及。微孔系统能够在高密度阵列中实现精确的细胞捕获和条码编码，在通量和可靠的资料品质之间取得平衡。同时，板式技术持续致力于解决需要对少量细胞进行深度定序的特殊应用。

评估2025年后即将实施​​的美国关税对单细胞定序进口和供应链的累积影响

美国拟议的关税将于2025年生效，这将透过提高关键设备、耗材和试剂的进口课税，对单细胞定序生态系统产生影响。製造商和最终用户可能会面临定序仪和微流体设备的更高到岸成本，这可能会促使供应链重组，并加速国内製造业的倡议。

关键细分洞察，用于指南单细胞定序产品类型、技术、最终用户和应用方面的策略决策

细緻入微地了解市场区隔对于使产品开发和上市策略与最终用户需求保持一致至关重要。根据产品类型，单细胞定序系统包括仪器和试剂/套件。仪器包括用于分离稀有亚群的专用细胞分选仪、支援微流体封装工作流程的微流体设备，以及针对单细胞读取深度最佳化的次世代定序仪。试剂和套件包括可维持转录本完整性的客製化扩增化学试剂、用于对多重样本进行索引的标记试剂套件，以及旨在最大程度地从单一细胞中回收核酸的裂解试剂套件。

解读影响美洲、中东和非洲以及亚太地区单细胞定序市场的区域动态和成长动力

区域动态将显着影响单细胞定序的普及和发展。在美洲，北美强大的学术生态系统正在推动尖端平台的早期应用，而主要的生物製药丛集正在加速向临床应用的转型。对国内製造和合作研究计画的投资将增强该地区创新和商业化新工作流程的能力。

确定推动单细胞定序技术创新与合作的领先公司的策略和竞争定位

产业领导者正在策略性地定位自身，以满足对单细胞定序平台和耗材日益增长的需求。 10x Genomics 和 Illumina 等仪器製造商不断改进其硬体设计，将微流体创新与先进的光学和流体处理技术相结合，以提高数据吞吐量和可靠性。作为这些努力的补充，包括 BD Biosciences 和 Fluidigm 在内的专业供应商提供承包解决方案，简化细胞捕获和条码编码流程，从而降低最终用户的工作流程复杂性。

为行业领导者提供可行的策略，以优化单细胞测序投资、优先考虑伙伴关係关係并应对不断变化的法规环境

产业领导者必须采取积极主动的方式，充分利用不断扩展的单细胞定序市场。投资应优先考虑联合开发伙伴关係，将仪器功能与尖端试剂化学技术结合，并确保在不同样本类型之间实现无缝的工作流程和验证。与领先的学术机构和製药公司建立联合技术蓝图，将有助于促进早期应用和联合品牌机会，从而提高市场渗透率。

严谨的调查方法的细节，结合了专家定性访谈、定量资料分析和全面的二次研究途径

我们的调查方法融合了定性和定量分析，旨在对单细胞测序领​​域进行全面而稳健的分析。主要研究包括对关键意见领袖（包括学术研究人员、临床实验室主任和製药研发高管）进行深入访谈，以收集关于技术采用障碍、工作流程偏好和新兴应用需求的第一手见解。

总结影响单细胞定序在前沿研究应用中发展轨蹟的关键见解的未来前景和战略意义

摘要：单细胞定序处于科学创新的前沿，打破了传统的细胞分辨率障碍，并促进了肿瘤学、免疫学、神经病学等领域的突破。随着新型液滴和微孔平台的普及以及整合化学技术简化工作流程，该技术有望再形成基础研究和临床诊断。

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章 市场概述

第五章市场动态

  • 整合多体学单细胞分析平台可实现全面的细胞分析和疾病路径洞察
  • 微流体高通量单细胞定序平台的进步降低了大规模研究的单细胞成本
  • 利用空间分辨转录组学和单细胞定序来保存组织结构和细胞相互作用
  • 越来越多地使用人工智慧和机器学习来对复杂的单细胞测序资料集进行可扩展的解释
  • 单细胞免疫组库定序的出现，用于绘製克隆多样性和表型标记表达图谱
  • 开发可携式奈米孔定序序装置，优化临床现场单细胞转录组分析
  • 开发使用 DNA 条码的样本多路復用策略，以提高大规模单细胞实验的通量并减少批次效应
  • 有针对性的单细胞表观基因检测的出现，可以同时进行染色质可及性和组蛋白修饰分析
  • 整合活细胞成像和单细胞RNA定序，将时间表型变化与转录组动态关联起来
  • 开发结合单细胞分离和文库製备的自动化平台，以简化临床诊断工作流程

第六章 市场洞察

  • 波特五力分析
  • PESTEL分析

第七章 2025年美国关税的累积影响

8. 单细胞定序市场（依产品类型）

  • 装置
    • 细胞分选装置
    • 微流体设备
    • 序列器
  • 试剂和套件
    • 扩增试剂套件
    • 标籤套件
    • 裂解试剂套件

9. 单细胞定序市场（依技术）

  • 基于液滴
  • 微孔板
  • 板基

10. 单细胞定序市场（依最终用户）

  • 学术研究
    • 研究机构
    • 大学
  • 临床诊断
    • 诊断实验室
    • 医院
  • 临床研究组织
    • 临床服务
    • 临床前服务
  • 製药和生物技术
    • 生物标誌物开发
    • 药物研发

11. 单细胞定序市场（依应用）

  • 癌症研究
    • 循环性肿瘤细胞
    • 肿瘤异质性
  • 发育生物学
  • 免疫学
    • 免疫组库分析
    • T细胞分析
  • 神经病学
    • 神经退化性疾病
    • 神经元分析

12. 美国单细胞定序市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 阿根廷

13. 欧洲、中东和非洲单细胞定序市场

  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 阿拉伯聯合大公国
  • 沙乌地阿拉伯
  • 南非
  • 丹麦
  • 荷兰
  • 卡达
  • 芬兰
  • 瑞典
  • 奈及利亚
  • 埃及
  • 土耳其
  • 以色列
  • 挪威
  • 波兰
  • 瑞士

14. 亚太地区单细胞定序市场

  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国
  • 印尼
  • 泰国
  • 菲律宾
  • 马来西亚
  • 新加坡
  • 越南
  • 台湾

第十五章竞争格局

  • 2024年市场占有率分析
  • 2024年FPNV定位矩阵
  • 竞争分析
    • Illumina, Inc.
    • Thermo Fisher Scientific, Inc.
    • 10x Genomics, Inc.
    • F. Hoffmann-La Roche Ltd
    • Bio-Rad Laboratories, Inc.
    • Becton, Dickinson and Company
    • Standard BioTools Inc.
    • Takara Bio Inc.
    • Miltenyi Biotec GmbH
    • Agilent Technologies, Inc.
    • Arima Genomics LLC
    • BGI Group
    • CD Genomics
    • Cell Signaling Technology, Inc.
    • HiFiBiO Therapeutics, Inc.
    • iRepertoire, Inc.
    • Merck KGaA
    • Oxford Nanopore Technologies plc.
    • Pacific Biosciences of California, Inc.
    • Parse Biosciences Inc.
    • QIAGEN GmbH
    • Revvity, Inc.

第十六章 研究人工智慧

第十七章 研究统计

第十八章 研究联络人

第十九章 研究报导

第二十章 附录

Product Code: MRR-035B5C3A4E3B

The Single Cell Sequencing Market was valued at USD 2.49 billion in 2024 and is projected to grow to USD 2.83 billion in 2025, with a CAGR of 13.94%, reaching USD 5.45 billion by 2030.

KEY MARKET STATISTICS
Base Year [2024] USD 2.49 billion
Estimated Year [2025] USD 2.83 billion
Forecast Year [2030] USD 5.45 billion
CAGR (%) 13.94%

Unveiling the transformative power of single cell sequencing in modern research and its critical role in shaping precision medicine and biotechnology breakthroughs

In the era of precision medicine and transformative biotechnology, single cell sequencing has emerged as a revolutionary tool that dissects cellular heterogeneity with unprecedented resolution. This technology enables researchers to unravel the complexity of tissues at the individual cell level, paving the way for breakthroughs in cancer biology, immunology, developmental biology, and beyond.

By capturing transcriptomic and genomic information from individual cells, scientists can identify rare cell populations, map differentiation trajectories, and characterize tumor microenvironments with a depth that bulk sequencing cannot achieve. As a result, single cell sequencing is redefining how we understand disease mechanisms, accelerating biomarker discovery, and informing the development of targeted therapies. With continuous innovations in instrumentation, chemistry, and computational analysis, the field is on the cusp of even greater sophistication and accessibility.

As research institutions, pharmaceutical companies, and clinical laboratories adopt these advanced workflows, the strategic importance of single cell sequencing grows. Decision-makers must understand the technological foundations and transformative potential of this field to harness its capabilities effectively. This introduction sets the stage for an in-depth exploration of the shifts, challenges, and opportunities that will shape the trajectory of single cell sequencing in the coming years.

Charting the evolution of single cell sequencing as emerging droplet and microwell technologies redefine research boundaries and clinical applications

Over the past decade, single cell sequencing has undergone transformative shifts driven by the rise of microfluidic droplet systems, microwell platforms, and high-throughput plate-based solutions. Droplet-based methods have democratized access by encapsulating individual cells in nanoliter droplets, enabling parallel processing of tens of thousands of cells in a single run. Microwell-based systems offer precise cell capture and barcoding in dense arrays, balancing throughput with robust data quality. Meanwhile, plate-based techniques continue to serve specialized applications requiring deep sequencing of fewer cells.

These technological leaps have been accompanied by advancements in library preparation chemistries, molecular barcoding strategies, and bioinformatic pipelines. As researchers demand greater sensitivity and lower input requirements, instrument vendors and reagent developers have responded with streamlined workflows and integrated analysis software. The convergence of hardware miniaturization and cloud-native data processing is further reducing barriers to entry, empowering academic laboratories and biotech startups alike.

Looking ahead, the landscape will be defined by continued integration of multi-omic approaches, spatial context preservation, and real-time data visualization. These emerging paradigms promise to expand the application scope of single cell sequencing, from early disease detection and immunoprofiling to monitoring therapeutic efficacy in clinical trials. Such shifts underscore the importance of staying abreast of platform innovations and aligning research strategies with evolving capabilities.

Assessing the cumulative impact of impending US tariffs on single cell sequencing imports and supply chains through 2025 and beyond

The proposed United States tariffs effective in 2025 are poised to influence the single cell sequencing ecosystem by increasing import levies on critical instruments, consumables, and reagents. Manufacturers and end users may face higher landed costs for sequencers and microfluidic devices, potentially prompting supply chain realignments and accelerated domestic manufacturing initiatives.

In response, many global instrument vendors are exploring localized assembly hubs to mitigate tariff impact while preserving price competitiveness. Parallel efforts by reagent suppliers to establish regional production facilities aim to ensure uninterrupted supply of barcoding chemistries, amplification kits, and labeling reagents. However, scaling local manufacturing involves rigorous validation processes and adherence to quality standards, which could introduce short-term bottlenecks.

As laboratories adjust procurement strategies, some may seek alternative suppliers or re-evaluate long-term service contracts, emphasizing total cost of ownership rather than unit price. Collaboration between instrument OEMs and reagent innovators will become even more critical to deliver integrated solutions that justify premium pricing through enhanced performance and support. Moreover, stakeholders should monitor policy developments closely, using scenario planning to anticipate further trade policy shifts.

Ultimately, the cumulative impact of these tariffs will hinge on the ability of the industry to adapt supply chain models, optimize inventory buffers, and leverage strategic partnerships to sustain momentum in high-impact research programs.

Illuminating key segmentation insights to guide strategic decisions across product types technologies end users and applications in single cell sequencing

A nuanced understanding of market segmentation is essential for aligning product development and go-to-market strategies with end-user needs. Based on product type, the single cell sequencing ecosystem encompasses both instruments and reagents and kits. Instruments span specialized cell sorters that isolate rare subpopulations, microfluidic devices that enable high-throughput encapsulation workflows, and next-generation sequencers optimized for single cell read depth. Reagents and kits comprise tailored amplification chemistries that preserve transcript integrity, labeling kits for multiplexed sample indexing, and lysis kits engineered to maximize nucleic acid recovery from individual cells.

In parallel, technological segmentation distinguishes droplet-based approaches, which excel in scalability; microwell-based platforms, which balance throughput and data fidelity; and plate-based solutions, which facilitate deep profiling of targeted cell cohorts. Each technology addresses unique research questions, from broad discovery studies to focused lineage tracing investigations.

End users range from academic research institutions-spanning both universities and independent research institutes-to clinical diagnostics laboratories and hospital centers where patient-derived samples inform precision oncology decisions. Clinical research organizations, subdivided into preclinical and clinical service providers, increasingly integrate single cell workflows into drug development pipelines. Similarly, pharmaceutical and biotech companies leverage these tools for biomarker discovery and drug screening, driving collaborations with instrument and reagent partners.

Applications further segment into cancer research, including studies of circulating tumor cells and tumor heterogeneity, developmental biology investigations, immunology analyses such as immune repertoire profiling and T cell functional assays, and neurological research focused on neurodegenerative disease models and neuronal cell type mapping. This layered segmentation framework empowers stakeholders to tailor solutions to the precise demands of diverse research and clinical markets.

Deciphering regional dynamics and growth drivers shaping the single cell sequencing market across Americas Europe Middle East Africa and Asia Pacific

Regional dynamics profoundly shape the adoption and evolution of single cell sequencing. In the Americas, robust academic ecosystems in North America drive early adoption of cutting-edge platforms, while leading biopharmaceutical clusters accelerate translation into clinical applications. Investment in domestic manufacturing and collaborative research initiatives bolsters the region's capacity to innovate and commercialize new workflows.

In Europe, Middle East, and Africa, cross-border consortia support large-scale population studies and translational research, leveraging harmonized regulatory frameworks and funding partnerships. European Union-led initiatives promote data sharing and standardization, facilitating multi-center studies in oncology, immunology, and neurobiology. Emerging markets in the Middle East and Africa are investing in infrastructure and training to integrate single cell techniques into regional health priorities.

Asia-Pacific exhibits the fastest growth trajectory, driven by strategic government funding programs, expanding biotechnology hubs, and a growing network of contract research organizations. Countries across the region are establishing centers of excellence focused on single cell genomics to support drug discovery and precision diagnostics. Local partnerships between instrument providers and regional distributors enhance accessibility and technical support, ensuring that researchers can fully leverage advanced sequencing platforms.

These distinct regional landscapes underscore the importance of tailored market entry and expansion strategies, from localized manufacturing and regulatory alignment to targeted collaborator networks.

Uncovering the strategies and competitive positioning of leading corporations driving innovation and collaboration in single cell sequencing technologies

Leading industry players have strategically positioned themselves to capitalize on the growing demand for single cell sequencing platforms and consumables. Instrument manufacturers such as 10x Genomics and Illumina continue to refine hardware designs, integrating microfluidic innovations with advanced optics and fluid handling to enhance data throughput and reliability. Complementing these efforts, specialized providers-including BD Biosciences and Fluidigm-offer turnkey solutions that streamline cell capture and barcoding, reducing workflow complexity for end users.

On the reagents front, companies like Takara Bio and Bio-Rad Laboratories have invested heavily in optimizing chemistries for single cell library preparation, focusing on sensitivity, specificity, and compatibility with diverse sample types. Meanwhile, emerging biotech firms are forging strategic alliances with large pharmaceutical organizations, co-developing custom assays tailored to high-value therapeutic areas such as immuno-oncology and regenerative medicine.

Collaborative partnerships between instrument OEMs, reagent suppliers, and software innovators are increasingly common, as integrated platforms become essential to address the data analysis bottleneck inherent to single cell studies. By uniting expertise in molecular biology, engineering, and bioinformatics, these consortia accelerate time-to-insight for researchers and bolster competitive moats through proprietary workflows and support services.

The success of these companies hinges on their ability to anticipate evolving user requirements, drive continuous innovation, and foster robust, user-centered ecosystems that extend beyond hardware and reagents into informatics and application support.

Empowering industry leaders with actionable strategies to optimize investment prioritize partnerships and navigate evolving regulatory environments in single cell sequencing

Industry leaders must adopt a proactive approach to capitalize on the expanding single cell sequencing landscape. Investments should prioritize co-development partnerships that align instrument capabilities with cutting-edge reagent chemistries, ensuring seamless workflows and validation across diverse sample types. Establishing joint technology roadmaps with key academic and pharmaceutical collaborators will foster early adoption and co-branding opportunities that enhance market penetration.

Building resilient supply chains is equally critical; diversifying manufacturing footprints and qualifying secondary suppliers will mitigate risks associated with geopolitical shifts, including tariff changes and trade restrictions. Leaders should implement agile inventory management systems to balance just-in-time delivery with strategic buffer stock, avoiding disruptions to high-priority research programs.

Embedding data analysis solutions within instrument offerings can create differentiated value propositions. By integrating cloud-native bioinformatics platforms and developing intuitive visualization tools, companies can lower the barrier to entry for laboratories lacking deep computational expertise. Tailored training programs, combined with certification pathways for single cell workflows, will reinforce customer loyalty and drive recurring revenue streams through reagent and service contracts.

Lastly, engaging with regulatory bodies and standardization consortia will position organizations to influence emerging guidelines for clinical translation of single cell assays. By contributing to best practice frameworks, leaders can accelerate approval pathways for diagnostic applications and solidify their role in the future of precision medicine.

Detailing a rigorous research methodology blending qualitative expert interviews quantitative data analysis and comprehensive secondary research approaches

Our research methodology integrates both qualitative and quantitative approaches to ensure a robust and comprehensive analysis of the single cell sequencing landscape. Primary research entailed in-depth interviews with key opinion leaders, including academic investigators, clinical laboratory directors, and pharmaceutical R&D executives, to gather firsthand insights on technology adoption barriers, workflow preferences, and emerging application needs.

On the quantitative side, publicly available data from peer-reviewed publications, conference proceedings, and patent filings were systematically analyzed to track technology maturation, funding trends, and geographic diffusion. We also mined instrument and reagent performance metrics to compare sensitivity, throughput, and cost-efficiency across competing platforms.

Secondary research leveraged industry white papers, regulatory filings, and corporate disclosures to validate primary findings and refine market segmentation. Cross-validation techniques were applied to reconcile disparate data sources, ensuring consistency and accuracy. Our analytical framework combined trend analysis, scenario modeling, and SWOT assessments to identify strategic imperatives and forecast potential market shifts.

This blended methodology, underpinned by continuous data quality checks and expert review panels, delivers actionable intelligence to support investment decisions, product development roadmaps, and go-to-market strategies in the fast-evolving single cell sequencing space.

Summarizing critical insights future outlook and strategic implications shaping the trajectory of single cell sequencing in cutting edge research applications

In summary, single cell sequencing stands at the forefront of scientific innovation, dismantling traditional barriers to cellular resolution and fueling breakthroughs across oncology, immunology, neurology, and beyond. As emerging droplet and microwell platforms democratize access, and integrated chemistries streamline workflows, the technology is poised to reshape both basic research and clinical diagnostics.

Navigating the evolving landscape requires a deep understanding of segmentation dynamics-from product typologies and technological modalities to end-user applications and geographic nuances. Concurrently, the industry must adapt to external pressures, including upcoming trade policies and shifting regulatory expectations. Leading organizations are already forging collaborative partnerships, investing in domestic supply chains, and embedding analytics solutions to maintain competitive advantage.

The strategic imperatives distilled here underscore the importance of aligning innovation with user needs, diversifying risk exposures, and proactively engaging in standards development. By synthesizing these insights, decision-makers can chart a path toward sustainable growth, operational resilience, and scientific leadership in an era where single cell technologies redefine what is possible in life science research.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Market Sizing & Forecasting

5. Market Dynamics

  • 5.1. Integration of multi-omics single cell analysis platforms to enable holistic cellular profiling and disease pathway insights
  • 5.2. Advances in microfluidic high-throughput single cell sequencing platforms driving reductions in cost per cell for large studies
  • 5.3. Adoption of spatially resolved transcriptomics in single cell sequencing to preserve tissue architecture and cell interactions
  • 5.4. Increased use of artificial intelligence and machine learning for scalable interpretation of complex single cell sequencing datasets
  • 5.5. Emergence of single cell immune repertoire sequencing to map clonal diversity alongside phenotypic marker expression
  • 5.6. Development of portable nanopore sequencing devices optimized for on site single cell transcriptomic analysis in clinics
  • 5.7. Growth of sample multiplexing strategies using DNA barcoding to increase throughput and reduce batch effects in large scale single cell experiments
  • 5.8. Emergence of targeted single cell epigenomics assays enabling simultaneous chromatin accessibility and histone modification profiling
  • 5.9. Integration of live cell imaging with single cell RNA sequencing to correlate temporal phenotypic changes with transcriptomic dynamics
  • 5.10. Development of automation platforms combining single cell isolation and library preparation for streamlined clinical diagnostics workflows

6. Market Insights

  • 6.1. Porter's Five Forces Analysis
  • 6.2. PESTLE Analysis

7. Cumulative Impact of United States Tariffs 2025

8. Single Cell Sequencing Market, by Product Type

  • 8.1. Introduction
  • 8.2. Instruments
    • 8.2.1. Cell Sorters
    • 8.2.2. Microfluidic Devices
    • 8.2.3. Sequencers
  • 8.3. Reagents And Kits
    • 8.3.1. Amplification Kits
    • 8.3.2. Labeling Kits
    • 8.3.3. Lysis Kits

9. Single Cell Sequencing Market, by Technology

  • 9.1. Introduction
  • 9.2. Droplet Based
  • 9.3. Microwell Based
  • 9.4. Plate Based

10. Single Cell Sequencing Market, by End User

  • 10.1. Introduction
  • 10.2. Academic Research
    • 10.2.1. Research Institutes
    • 10.2.2. Universities
  • 10.3. Clinical Diagnostics
    • 10.3.1. Diagnostic Labs
    • 10.3.2. Hospitals
  • 10.4. Clinical Research Organization
    • 10.4.1. Clinical Services
    • 10.4.2. Preclinical Services
  • 10.5. Pharma & Biotech
    • 10.5.1. Biomarker Development
    • 10.5.2. Drug Discovery

11. Single Cell Sequencing Market, by Application

  • 11.1. Introduction
  • 11.2. Cancer Research
    • 11.2.1. Circulating Tumor Cells
    • 11.2.2. Tumor Heterogeneity
  • 11.3. Developmental Biology
  • 11.4. Immunology
    • 11.4.1. Immune Repertoire Analysis
    • 11.4.2. T Cell Profiling
  • 11.5. Neurology
    • 11.5.1. Neurodegenerative Disease
    • 11.5.2. Neuronal Profiling

12. Americas Single Cell Sequencing Market

  • 12.1. Introduction
  • 12.2. United States
  • 12.3. Canada
  • 12.4. Mexico
  • 12.5. Brazil
  • 12.6. Argentina

13. Europe, Middle East & Africa Single Cell Sequencing Market

  • 13.1. Introduction
  • 13.2. United Kingdom
  • 13.3. Germany
  • 13.4. France
  • 13.5. Russia
  • 13.6. Italy
  • 13.7. Spain
  • 13.8. United Arab Emirates
  • 13.9. Saudi Arabia
  • 13.10. South Africa
  • 13.11. Denmark
  • 13.12. Netherlands
  • 13.13. Qatar
  • 13.14. Finland
  • 13.15. Sweden
  • 13.16. Nigeria
  • 13.17. Egypt
  • 13.18. Turkey
  • 13.19. Israel
  • 13.20. Norway
  • 13.21. Poland
  • 13.22. Switzerland

14. Asia-Pacific Single Cell Sequencing Market

  • 14.1. Introduction
  • 14.2. China
  • 14.3. India
  • 14.4. Japan
  • 14.5. Australia
  • 14.6. South Korea
  • 14.7. Indonesia
  • 14.8. Thailand
  • 14.9. Philippines
  • 14.10. Malaysia
  • 14.11. Singapore
  • 14.12. Vietnam
  • 14.13. Taiwan

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2024
  • 15.2. FPNV Positioning Matrix, 2024
  • 15.3. Competitive Analysis
    • 15.3.1. Illumina, Inc.
    • 15.3.2. Thermo Fisher Scientific, Inc.
    • 15.3.3. 10x Genomics, Inc.
    • 15.3.4. F. Hoffmann-La Roche Ltd
    • 15.3.5. Bio-Rad Laboratories, Inc.
    • 15.3.6. Becton, Dickinson and Company
    • 15.3.7. Standard BioTools Inc.
    • 15.3.8. Takara Bio Inc.
    • 15.3.9. Miltenyi Biotec GmbH
    • 15.3.10. Agilent Technologies, Inc.
    • 15.3.11. Arima Genomics LLC
    • 15.3.12. BGI Group
    • 15.3.13. CD Genomics
    • 15.3.14. Cell Signaling Technology, Inc.
    • 15.3.15. HiFiBiO Therapeutics, Inc.
    • 15.3.16. iRepertoire, Inc.
    • 15.3.17. Merck KGaA
    • 15.3.18. Oxford Nanopore Technologies plc.
    • 15.3.19. Pacific Biosciences of California, Inc.
    • 15.3.20. Parse Biosciences Inc.
    • 15.3.21. QIAGEN GmbH
    • 15.3.22. Revvity, Inc.

16. ResearchAI

17. ResearchStatistics

18. ResearchContacts

19. ResearchArticles

20. Appendix

LIST OF FIGURES

  • FIGURE 1. SINGLE CELL SEQUENCING MARKET RESEARCH PROCESS
  • FIGURE 2. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 3. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 4. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
  • FIGURE 6. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 7. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
  • FIGURE 8. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY END USER, 2024 VS 2030 (%)
  • FIGURE 10. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
  • FIGURE 12. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 13. AMERICAS SINGLE CELL SEQUENCING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 14. AMERICAS SINGLE CELL SEQUENCING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES SINGLE CELL SEQUENCING MARKET SIZE, BY STATE, 2024 VS 2030 (%)
  • FIGURE 16. UNITED STATES SINGLE CELL SEQUENCING MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA SINGLE CELL SEQUENCING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA SINGLE CELL SEQUENCING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 19. ASIA-PACIFIC SINGLE CELL SEQUENCING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 20. ASIA-PACIFIC SINGLE CELL SEQUENCING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 21. SINGLE CELL SEQUENCING MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 22. SINGLE CELL SEQUENCING MARKET, FPNV POSITIONING MATRIX, 2024
  • FIGURE 23. SINGLE CELL SEQUENCING MARKET: RESEARCHAI
  • FIGURE 24. SINGLE CELL SEQUENCING MARKET: RESEARCHSTATISTICS
  • FIGURE 25. SINGLE CELL SEQUENCING MARKET: RESEARCHCONTACTS
  • FIGURE 26. SINGLE CELL SEQUENCING MARKET: RESEARCHARTICLES

LIST OF TABLES

  • TABLE 1. SINGLE CELL SEQUENCING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, 2025-2030 (USD MILLION)
  • TABLE 5. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 7. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 9. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 11. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 13. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY CELL SORTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY CELL SORTERS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 15. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY MICROFLUIDIC DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY MICROFLUIDIC DEVICES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 17. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY SEQUENCERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY SEQUENCERS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 19. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
  • TABLE 21. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY REAGENTS AND KITS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY REAGENTS AND KITS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 23. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY AMPLIFICATION KITS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY AMPLIFICATION KITS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 25. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY LABELING KITS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY LABELING KITS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 27. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY LYSIS KITS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY LYSIS KITS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 29. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY REAGENTS AND KITS, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY REAGENTS AND KITS, 2025-2030 (USD MILLION)
  • TABLE 31. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 33. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY DROPLET BASED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY DROPLET BASED, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 35. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY MICROWELL BASED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY MICROWELL BASED, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 37. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY PLATE BASED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY PLATE BASED, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 39. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 41. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY ACADEMIC RESEARCH, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY ACADEMIC RESEARCH, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 43. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 45. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY UNIVERSITIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY UNIVERSITIES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 47. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY ACADEMIC RESEARCH, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY ACADEMIC RESEARCH, 2025-2030 (USD MILLION)
  • TABLE 49. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 51. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY DIAGNOSTIC LABS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY DIAGNOSTIC LABS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 53. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 55. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2030 (USD MILLION)
  • TABLE 57. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY CLINICAL RESEARCH ORGANIZATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY CLINICAL RESEARCH ORGANIZATION, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 59. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY CLINICAL SERVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY CLINICAL SERVICES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 61. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY PRECLINICAL SERVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY PRECLINICAL SERVICES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 63. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY CLINICAL RESEARCH ORGANIZATION, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY CLINICAL RESEARCH ORGANIZATION, 2025-2030 (USD MILLION)
  • TABLE 65. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY PHARMA & BIOTECH, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY PHARMA & BIOTECH, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 67. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY BIOMARKER DEVELOPMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY BIOMARKER DEVELOPMENT, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 69. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 71. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY PHARMA & BIOTECH, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY PHARMA & BIOTECH, 2025-2030 (USD MILLION)
  • TABLE 73. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 75. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY CANCER RESEARCH, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY CANCER RESEARCH, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 77. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY CIRCULATING TUMOR CELLS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY CIRCULATING TUMOR CELLS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 79. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY TUMOR HETEROGENEITY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY TUMOR HETEROGENEITY, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 81. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY CANCER RESEARCH, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY CANCER RESEARCH, 2025-2030 (USD MILLION)
  • TABLE 83. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY DEVELOPMENTAL BIOLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY DEVELOPMENTAL BIOLOGY, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 85. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY IMMUNOLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY IMMUNOLOGY, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 87. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY IMMUNE REPERTOIRE ANALYSIS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY IMMUNE REPERTOIRE ANALYSIS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 89. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY T CELL PROFILING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY T CELL PROFILING, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 91. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY IMMUNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY IMMUNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 93. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY NEUROLOGY, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 95. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY NEURODEGENERATIVE DISEASE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY NEURODEGENERATIVE DISEASE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 97. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY NEURONAL PROFILING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY NEURONAL PROFILING, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 99. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY NEUROLOGY, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY NEUROLOGY, 2025-2030 (USD MILLION)
  • TABLE 101. AMERICAS SINGLE CELL SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 102. AMERICAS SINGLE CELL SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 103. AMERICAS SINGLE CELL SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 104. AMERICAS SINGLE CELL SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
  • TABLE 105. AMERICAS SINGLE CELL SEQUENCING MARKET SIZE, BY REAGENTS AND KITS, 2018-2024 (USD MILLION)
  • TABLE 106. AMERICAS SINGLE CELL SEQUENCING MARKET SIZE, BY REAGENTS AND KITS, 2025-2030 (USD MILLION)
  • TABLE 107. AMERICAS SINGLE CELL SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 108. AMERICAS SINGLE CELL SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 109. AMERICAS SINGLE CELL SEQUENCING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 110. AMERICAS SINGLE CELL SEQUENCING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 111. AMERICAS SINGLE CELL SEQUENCING MARKET SIZE, BY ACADEMIC RESEARCH, 2018-2024 (USD MILLION)
  • TABLE 112. AMERICAS SINGLE CELL SEQUENCING MARKET SIZE, BY ACADEMIC RESEARCH, 2025-2030 (USD MILLION)
  • TABLE 113. AMERICAS SINGLE CELL SEQUENCING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 114. AMERICAS SINGLE CELL SEQUENCING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2030 (USD MILLION)
  • TABLE 115. AMERICAS SINGLE CELL SEQUENCING MARKET SIZE, BY CLINICAL RESEARCH ORGANIZATION, 2018-2024 (USD MILLION)
  • TABLE 116. AMERICAS SINGLE CELL SEQUENCING MARKET SIZE, BY CLINICAL RESEARCH ORGANIZATION, 2025-2030 (USD MILLION)
  • TABLE 117. AMERICAS SINGLE CELL SEQUENCING MARKET SIZE, BY PHARMA & BIOTECH, 2018-2024 (USD MILLION)
  • TABLE 118. AMERICAS SINGLE CELL SEQUENCING MARKET SIZE, BY PHARMA & BIOTECH, 2025-2030 (USD MILLION)
  • TABLE 119. AMERICAS SINGLE CELL SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 120. AMERICAS SINGLE CELL SEQUENCING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 121. AMERICAS SINGLE CELL SEQUENCING MARKET SIZE, BY CANCER RESEARCH, 2018-2024 (USD MILLION)
  • TABLE 122. AMERICAS SINGLE CELL SEQUENCING MARKET SIZE, BY CANCER RESEARCH, 2025-2030 (USD MILLION)
  • TABLE 123. AMERICAS SINGLE CELL SEQUENCING MARKET SIZE, BY IMMUNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 124. AMERICAS SINGLE CELL SEQUENCING MARKET SIZE, BY IMMUNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 125. AMERICAS SINGLE CELL SEQUENCING MARKET SIZE, BY NEUROLOGY, 2018-2024 (USD MILLION)
  • TABLE 126. AMERICAS SINGLE CELL SEQUENCING MARKET SIZE, BY NEUROLOGY, 2025-2030 (USD MILLION)
  • TABLE 127. AMERICAS SINGLE CELL SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 128. AMERICAS SINGLE CELL SEQUENCING MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 129. UNITED STATES SINGLE CELL SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 130. UNITED STATES SINGLE CELL SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 131. UNITED STATES SINGLE CELL SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 132. UNITED STATES SINGLE CELL SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
  • TABLE 133. UNITED STATES SINGLE CELL SEQUENCING MARKET SIZE, BY REAGENTS AND KITS, 2018-2024 (USD MILLION)
  • TABLE 134. UNITED STATES SINGLE CELL SEQUENCING MARKET SIZE, BY REAGENTS AND KITS, 2025-2030 (USD MILLION)
  • TABLE 135. UNITED STATES SINGLE CELL SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 136. UNITED STATES SINGLE CELL SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 137. UNITED STATES SINGLE CELL SEQUENCING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 138. UNITED STATES SINGLE CELL SEQUENCING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 139. UNITED STATES SINGLE CELL SEQUENCING MARKET SIZE, BY ACADEMIC RESEARCH, 2018-2024 (USD MILLION)
  • TABLE 140. UNITED STATES SINGLE CELL SEQUENCING MARKET SIZE, BY ACADEMIC RESEARCH, 2025-2030 (USD MILLION)
  • TABLE 141. UNITED STATES SINGLE CELL SEQUENCING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 142. UNITED STATES SINGLE CELL SEQUENCING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2030 (USD MILLION)
  • TABLE 143. UNITED STATES SINGLE CELL SEQUENCING MARKET SIZE, BY CLINICAL RESEARCH ORGANIZATION, 2018-2024 (USD MILLION)
  • TABLE 144. UNITED STATES SINGLE CELL SEQUENCING MARKET SIZE, BY CLINICAL RESEARCH ORGANIZATION, 2025-2030 (USD MILLION)
  • TABLE 145. UNITED STATES SINGLE CELL SEQUENCING MARKET SIZE, BY PHARMA & BIOTECH, 2018-2024 (USD MILLION)
  • TABLE 146. UNITED STATES SINGLE CELL SEQUENCING MARKET SIZE, BY PHARMA & BIOTECH, 2025-2030 (USD MILLION)
  • TABLE 147. UNITED STATES SINGLE CELL SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 148. UNITED STATES SINGLE CELL SEQUENCING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 149. UNITED STATES SINGLE CELL SEQUENCING MARKET SIZE, BY CANCER RESEARCH, 2018-2024 (USD MILLION)
  • TABLE 150. UNITED STATES SINGLE CELL SEQUENCING MARKET SIZE, BY CANCER RESEARCH, 2025-2030 (USD MILLION)
  • TABLE 151. UNITED STATES SINGLE CELL SEQUENCING MARKET SIZE, BY IMMUNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 152. UNITED STATES SINGLE CELL SEQUENCING MARKET SIZE, BY IMMUNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 153. UNITED STATES SINGLE CELL SEQUENCING MARKET SIZE, BY NEUROLOGY, 2018-2024 (USD MILLION)
  • TABLE 154. UNITED STATES SINGLE CELL SEQUENCING MARKET SIZE, BY NEUROLOGY, 2025-2030 (USD MILLION)
  • TABLE 155. UNITED STATES SINGLE CELL SEQUENCING MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
  • TABLE 156. UNITED STATES SINGLE CELL SEQUENCING MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
  • TABLE 157. CANADA SINGLE CELL SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 158. CANADA SINGLE CELL SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 159. CANADA SINGLE CELL SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 160. CANADA SINGLE CELL SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
  • TABLE 161. CANADA SINGLE CELL SEQUENCING MARKET SIZE, BY REAGENTS AND KITS, 2018-2024 (USD MILLION)
  • TABLE 162. CANADA SINGLE CELL SEQUENCING MARKET SIZE, BY REAGENTS AND KITS, 2025-2030 (USD MILLION)
  • TABLE 163. CANADA SINGLE CELL SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 164. CANADA SINGLE CELL SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 165. CANADA SINGLE CELL SEQUENCING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 166. CANADA SINGLE CELL SEQUENCING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 167. CANADA SINGLE CELL SEQUENCING MARKET SIZE, BY ACADEMIC RESEARCH, 2018-2024 (USD MILLION)
  • TABLE 168. CANADA SINGLE CELL SEQUENCING MARKET SIZE, BY ACADEMIC RESEARCH, 2025-2030 (USD MILLION)
  • TABLE 169. CANADA SINGLE CELL SEQUENCING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 170. CANADA SINGLE CELL SEQUENCING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2030 (USD MILLION)
  • TABLE 171. CANADA SINGLE CELL SEQUENCING MARKET SIZE, BY CLINICAL RESEARCH ORGANIZATION, 2018-2024 (USD MILLION)
  • TABLE 172. CANADA SINGLE CELL SEQUENCING MARKET SIZE, BY CLINICAL RESEARCH ORGANIZATION, 2025-2030 (USD MILLION)
  • TABLE 173. CANADA SINGLE CELL SEQUENCING MARKET SIZE, BY PHARMA & BIOTECH, 2018-2024 (USD MILLION)
  • TABLE 174. CANADA SINGLE CELL SEQUENCING MARKET SIZE, BY PHARMA & BIOTECH, 2025-2030 (USD MILLION)
  • TABLE 175. CANADA SINGLE CELL SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 176. CANADA SINGLE CELL SEQUENCING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 177. CANADA SINGLE CELL SEQUENCING MARKET SIZE, BY CANCER RESEARCH, 2018-2024 (USD MILLION)
  • TABLE 178. CANADA SINGLE CELL SEQUENCING MARKET SIZE, BY CANCER RESEARCH, 2025-2030 (USD MILLION)
  • TABLE 179. CANADA SINGLE CELL SEQUENCING MARKET SIZE, BY IMMUNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 180. CANADA SINGLE CELL SEQUENCING MARKET SIZE, BY IMMUNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 181. CANADA SINGLE CELL SEQUENCING MARKET SIZE, BY NEUROLOGY, 2018-2024 (USD MILLION)
  • TABLE 182. CANADA SINGLE CELL SEQUENCING MARKET SIZE, BY NEUROLOGY, 2025-2030 (USD MILLION)
  • TABLE 183. MEXICO SINGLE CELL SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 184. MEXICO SINGLE CELL SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 185. MEXICO SINGLE CELL SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 186. MEXICO SINGLE CELL SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
  • TABLE 187. MEXICO SINGLE CELL SEQUENCING MARKET SIZE, BY REAGENTS AND KITS, 2018-2024 (USD MILLION)
  • TABLE 188. MEXICO SINGLE CELL SEQUENCING MARKET SIZE, BY REAGENTS AND KITS, 2025-2030 (USD MILLION)
  • TABLE 189. MEXICO SINGLE CELL SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 190. MEXICO SINGLE CELL SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 191. MEXICO SINGLE CELL SEQUENCING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 192. MEXICO SINGLE CELL SEQUENCING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 193. MEXICO SINGLE CELL SEQUENCING MARKET SIZE, BY ACADEMIC RESEARCH, 2018-2024 (USD MILLION)
  • TABLE 194. MEXICO SINGLE CELL SEQUENCING MARKET SIZE, BY ACADEMIC RESEARCH, 2025-2030 (USD MILLION)
  • TABLE 195. MEXICO SINGLE CELL SEQUENCING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 196. MEXICO SINGLE CELL SEQUENCING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2030 (USD MILLION)
  • TABLE 197. MEXICO SINGLE CELL SEQUENCING MARKET SIZE, BY CLINICAL RESEARCH ORGANIZATION, 2018-2024 (USD MILLION)
  • TABLE 198. MEXICO SINGLE CELL SEQUENCING MARKET SIZE, BY CLINICAL RESEARCH ORGANIZATION, 2025-2030 (USD MILLION)
  • TABLE 199. MEXICO SINGLE CELL SEQUENCING MARKET SIZE, BY PHARMA & BIOTECH, 2018-2024 (USD MILLION)
  • TABLE 200. MEXICO SINGLE CELL SEQUENCING MARKET SIZE, BY PHARMA & BIOTECH, 2025-2030 (USD MILLION)
  • TABLE 201. MEXICO SINGLE CELL SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 202. MEXICO SINGLE CELL SEQUENCING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 203. MEXICO SINGLE CELL SEQUENCING MARKET SIZE, BY CANCER RESEARCH, 2018-2024 (USD MILLION)
  • TABLE 204. MEXICO SINGLE CELL SEQUENCING MARKET SIZE, BY CANCER RESEARCH, 2025-2030 (USD MILLION)
  • TABLE 205. MEXICO SINGLE CELL SEQUENCING MARKET SIZE, BY IMMUNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 206. MEXICO SINGLE CELL SEQUENCING MARKET SIZE, BY IMMUNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 207. MEXICO SINGLE CELL SEQUENCING MARKET SIZE, BY NEUROLOGY, 2018-2024 (USD MILLION)
  • TABLE 208. MEXICO SINGLE CELL SEQUENCING MARKET SIZE, BY NEUROLOGY, 2025-2030 (USD MILLION)
  • TABLE 209. BRAZIL SINGLE CELL SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 210. BRAZIL SINGLE CELL SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 211. BRAZIL SINGLE CELL SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 212. BRAZIL SINGLE CELL SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
  • TABLE 213. BRAZIL SINGLE CELL SEQUENCING MARKET SIZE, BY REAGENTS AND KITS, 2018-2024 (USD MILLION)
  • TABLE 214. BRAZIL SINGLE CELL SEQUENCING MARKET SIZE, BY REAGENTS AND KITS, 2025-2030 (USD MILLION)
  • TABLE 215. BRAZIL SINGLE CELL SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 216. BRAZIL SINGLE CELL SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 217. BRAZIL SINGLE CELL SEQUENCING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 218. BRAZIL SINGLE CELL SEQUENCING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 219. BRAZIL SINGLE CELL SEQUENCING MARKET SIZE, BY ACADEMIC RESEARCH, 2018-2024 (USD MILLION)
  • TABLE 220. BRAZIL SINGLE CELL SEQUENCING MARKET SIZE, BY ACADEMIC RESEARCH, 2025-2030 (USD MILLION)
  • TABLE 221. BRAZIL SINGLE CELL SEQUENCING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 222. BRAZIL SINGLE CELL SEQUENCING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2030 (USD MILLION)
  • TABLE 223. BRAZIL SINGLE CELL SEQUENCING MARKET SIZE, BY CLINICAL RESEARCH ORGANIZATION, 2018-2024 (USD MILLION)
  • TABLE 224. BRAZIL SINGLE CELL SEQUENCING MARKET SIZE, BY CLINICAL RESEARCH ORGANIZATION, 2025-2030 (USD MILLION)
  • TABLE 225. BRAZIL SINGLE CELL SEQUENCING MARKET SIZE, BY PHARMA & BIOTECH, 2018-2024 (USD MILLION)
  • TABLE 226. BRAZIL SINGLE CELL SEQUENCING MARKET SIZE, BY PHARMA & BIOTECH, 2025-2030 (USD MILLION)
  • TABLE 227. BRAZIL SINGLE CELL SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 228. BRAZIL SINGLE CELL SEQUENCING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 229. BRAZIL SINGLE CELL SEQUENCING MARKET SIZE, BY CANCER RESEARCH, 2018-2024 (USD MILLION)
  • TABLE 230. BRAZIL SINGLE CELL SEQUENCING MARKET SIZE, BY CANCER RESEARCH, 2025-2030 (USD MILLION)
  • TABLE 231. BRAZIL SINGLE CELL SEQUENCING MARKET SIZE, BY IMMUNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 232. BRAZIL SINGLE CELL SEQUENCING MARKET SIZE, BY IMMUNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 233. BRAZIL SINGLE CELL SEQUENCING MARKET SIZE, BY NEUROLOGY, 2018-2024 (USD MILLION)
  • TABLE 234. BRAZIL SINGLE CELL SEQUENCING MARKET SIZE, BY NEUROLOGY, 2025-2030 (USD MILLION)
  • TABLE 235. ARGENTINA SINGLE CELL SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 236. ARGENTINA SINGLE CELL SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 237. ARGENTINA SINGLE CELL SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 238. ARGENTINA SINGLE CELL SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
  • TABLE 239. ARGENTINA SINGLE CELL SEQUENCING MARKET SIZE, BY REAGENTS AND KITS, 2018-2024 (USD MILLION)
  • TABLE 240. ARGENTINA SINGLE CELL SEQUENCING MARKET SIZE, BY REAGENTS AND KITS, 2025-2030 (USD MILLION)
  • TABLE 241. ARGENTINA SINGLE CELL SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 242. ARGENTINA SINGLE CELL SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 243. ARGENTINA SINGLE CELL SEQUENCING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 244. ARGENTINA SINGLE CELL SEQUENCING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 245. ARGENTINA SINGLE CELL SEQUENCING MARKET SIZE, BY ACADEMIC RESEARCH, 2018-2024 (USD MILLION)
  • TABLE 246. ARGENTINA SINGLE CELL SEQUENCING MARKET SIZE, BY ACADEMIC RESEARCH, 2025-2030 (USD MILLION)
  • TABLE 247. ARGENTINA SINGLE CELL SEQUENCING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 248. ARGENTINA SINGLE CELL SEQUENCING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2030 (USD MILLION)
  • TABLE 249. ARGENTINA SINGLE CELL SEQUENCING MARKET SIZE, BY CLINICAL RESEARCH ORGANIZATION, 2018-2024 (USD MILLION)
  • TABLE 250. ARGENTINA SINGLE CELL SEQUENCING MARKET SIZE, BY CLINICAL RESEARCH ORGANIZATION, 2025-2030 (USD MILLION)
  • TABLE 251. ARGENTINA SINGLE CELL SEQUENCING MARKET SIZE, BY PHARMA & BIOTECH, 2018-2024 (USD MILLION)
  • TABLE 252. ARGENTINA SINGLE CELL SEQUENCING MARKET SIZE, BY PHARMA & BIOTECH, 2025-2030 (USD MILLION)
  • TABLE 253. ARGENTINA SINGLE CELL SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 254. ARGENTINA SINGLE CELL SEQUENCING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 255. ARGENTINA SINGLE CELL SEQUENCING MARKET SIZE, BY CANCER RESEARCH, 2018-2024 (USD MILLION)
  • TABLE 256. ARGENTINA SINGLE CELL SEQUENCING MARKET SIZE, BY CANCER RESEARCH, 2025-2030 (USD MILLION)
  • TABLE 257. ARGENTINA SINGLE CELL SEQUENCING MARKET SIZE, BY IMMUNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 258. ARGENTINA SINGLE CELL SEQUENCING MARKET SIZE, BY IMMUNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 259. ARGENTINA SINGLE CELL SEQUENCING MARKET SIZE, BY NEUROLOGY, 2018-2024 (USD MILLION)
  • TABLE 260. ARGENTINA SINGLE CELL SEQUENCING MARKET SIZE, BY NEUROLOGY, 2025-2030 (USD MILLION)
  • TABLE 261. EUROPE, MIDDLE EAST & AFRICA SINGLE CELL SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 262. EUROPE, MIDDLE EAST & AFRICA SINGLE CELL SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 263. EUROPE, MIDDLE EAST & AFRICA SINGLE CELL SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 264. EUROPE, MIDDLE EAST & AFRICA SINGLE CELL SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
  • TABLE 265. EUROPE, MIDDLE EAST & AFRICA SINGLE CELL SEQUENCING MARKET SIZE, BY REAGENTS AND KITS, 2018-2024 (USD MILLION)
  • TABLE 266. EUROPE, MIDDLE EAST & AFRICA SINGLE CELL SEQUENCING MARKET SIZE, BY REAGENTS AND KITS, 2025-2030 (USD MILLION)
  • TABLE 267. EUROPE, MIDDLE EAST & AFRICA SINGLE CELL SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 268. EUROPE, MIDDLE EAST & AFRICA SINGLE CELL SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 269. EUROPE, MIDDLE EAST & AFRICA SINGLE CELL SEQUENCING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 270. EUROPE, MIDDLE EAST & AFRICA SINGLE CELL SEQUENCING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 271. EUROPE, MIDDLE EAST & AFRICA SINGLE CELL SEQUENCING MARKET SIZE, BY ACADEMIC RESEARCH, 2018-2024 (USD MILLION)
  • TABLE 272. EUROPE, MIDDLE EAST & AFRICA SINGLE CELL SEQUENCING MARKET SIZE, BY ACADEMIC RESEARCH, 2025-2030 (USD MILLION)
  • TABLE 273. EUROPE, MIDDLE EAST & AFRICA SINGLE CELL SEQUENCING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 274. EUROPE, MIDDLE EAST & AFRICA SINGLE CELL SEQUENCING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2030 (USD MILLION)
  • TABLE 275. EUROPE, MIDDLE EAST & AFRICA SINGLE CELL SEQUENCING MARKET SIZE, BY CLINICAL RESEARCH ORGANIZATION, 2018-2024 (USD MILLION)
  • TABLE 276. EUROPE, MIDDLE EAST & AFRICA SINGLE CELL SEQUENCING MARKET SIZE, BY CLINICAL RESEARCH ORGANIZATION, 2025-2030 (USD MILLION)
  • TABLE 277. EUROPE, MIDDLE EAST & AFRICA SINGLE CELL SEQUENCING MARKET SIZE, BY PHARMA & BIOTECH, 2018-2024 (USD MILLION)
  • TABLE 278. EUROPE, MIDDLE EAST & AFRICA SINGLE CELL SEQUENCING MARKET SIZE, BY PHARMA & BIOTECH, 2025-2030 (USD MILLION)
  • TABLE 279. EUROPE, MIDDLE EAST & AFRICA SINGLE CELL SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 280. EUROPE, MIDDLE EAST & AFRICA SINGLE CELL SEQUENCING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 281. EUROPE, MIDDLE EAST & AFRICA SINGLE CELL SEQUENCING MARKET SIZE, BY CANCER RESEARCH, 2018-2024 (USD MILLION)
  • TABLE 282. EUROPE, MIDDLE EAST & AFRICA SINGLE CELL SEQUENCING MARKET SIZE, BY CANCER RESEARCH, 2025-2030 (USD MILLION)
  • TABLE 283. EUROPE, MIDDLE EAST & AFRICA SINGLE CELL SEQUENCING MARKET SIZE, BY IMMUNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 284. EUROPE, MIDDLE EAST & AFRICA SINGLE CELL SEQUENCING MARKET SIZE, BY IMMUNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 285. EUROPE, MIDDLE EAST & AFRICA SINGLE CELL SEQUENCING MARKET SIZE, BY NEUROLOGY, 2018-2024 (USD MILLION)
  • TABLE 286. EUROPE, MIDDLE EAST & AFRICA SINGLE CELL SEQUENCING MARKET SIZE, BY NEUROLOGY, 2025-2030 (USD MILLION)
  • TABLE 287. EUROPE, MIDDLE EAST & AFRICA SINGLE CELL SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 288. EUROPE, MIDDLE EAST & AFRICA SINGLE CELL SEQUENCING MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 289. UNITED KINGDOM SINGLE CELL SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 290. UNITED KINGDOM SINGLE CELL SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 291. UNITED KINGDOM SINGLE CELL SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 292. UNITED KINGDOM SINGLE CELL SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
  • TABLE 293. UNITED KINGDOM SINGLE CELL SEQUENCING MARKET SIZE, BY REAGENTS AND KITS, 2018-2024 (USD MILLION)
  • TABLE 294. UNITED KINGDOM SINGLE CELL SEQUENCING MARKET SIZE, BY REAGENTS AND KITS, 2025-2030 (USD MILLION)
  • TABLE 295. UNITED KINGDOM SINGLE CELL SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 296. UNITED KINGDOM SINGLE CELL SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 297. UNITED KINGDOM SINGLE CELL SEQUENCING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 298. UNITED KINGDOM SINGLE CELL SEQUENCING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 299. UNITED KINGDOM SINGLE CELL SEQUENCING MARKET SIZE, BY ACADEMIC RESEARCH, 2018-2024 (USD MILLION)
  • TABLE 300. UNITED KINGDOM SINGLE CELL SEQUENCING MARKET SIZE, BY ACADEMIC RESEARCH, 2025-2030 (USD MILLION)
  • TABLE 301. UNITED KINGDOM SINGLE CELL SEQUENCING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 302. UNITED KINGDOM SINGLE CELL SEQUENCING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2030 (USD MILLION)
  • TABLE 303. UNITED KINGDOM SINGLE CELL SEQUENCING MARKET SIZE, BY CLINICAL RESEARCH ORGANIZATION, 2018-2024 (USD MILLION)
  • TABLE 304. UNITED KINGDOM SINGLE CELL SEQUENCING MARKET SIZE, BY CLINICAL RESEARCH ORGANIZATION, 2025-2030 (USD MILLION)
  • TABLE 305. UNITED KINGDOM SINGLE CELL SEQUENCING MARKET SIZE, BY PHARMA & BIOTECH, 2018-2024 (USD MILLION)
  • TABLE 306. UNITED KINGDOM SINGLE CELL SEQUENCING MARKET SIZE, BY PHARMA & BIOTECH, 2025-2030 (USD MILLION)
  • TABLE 307. UNITED KINGDOM SINGLE CELL SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 308. UNITED KINGDOM SINGLE CELL SEQUENCING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 309. UNITED KINGDOM SINGLE CELL SEQUENCING MARKET SIZE, BY CANCER RESEARCH, 2018-2024 (USD MILLION)
  • TABLE 310. UNITED KINGDOM SINGLE CELL SEQUENCING MARKET SIZE, BY CANCER RESEARCH, 2025-2030 (USD MILLION)
  • TABLE 311. UNITED KINGDOM SINGLE CELL SEQUENCING MARKET SIZE, BY IMMUNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 312. UNITED KINGDOM SINGLE CELL SEQUENCING MARKET SIZE, BY IMMUNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 313. UNITED KINGDOM SINGLE CELL SEQUENCING MARKET SIZE, BY NEUROLOGY, 2018-2024 (USD MILLION)
  • TABLE 314. UNITED KINGDOM SINGLE CELL SEQUENCING MARKET SIZE, BY NEUROLOGY, 2025-2030 (USD MILLION)
  • TABLE 315. GERMANY SINGLE CELL SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 316. GERMANY SINGLE CELL SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 317. GERMANY SINGLE CELL SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 318. GERMANY SINGLE CELL SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
  • TABLE 319. GERMANY SINGLE CELL SEQUENCING MARKET SIZE, BY REAGENTS AND KITS, 2018-2024 (USD MILLION)

TABLE